STP609

    Packaging Requirements for New Drug Applications

    Published: Jan 1976


      Format Pages Price  
    PDF Version (128K) 8 $25   ADD TO CART
    Complete Source PDF (1.8M) 8 $55   ADD TO CART


    Abstract

    The regulatory responsibilities of the Food and Drug Administration and the Consumer Product Safety Commission, under the Federal Food, Drug, and Cosmetic Act and the Poison Prevention Packaging Act of 1970, as they pertain to safety packaging, are reviewed. Details are given on container information required in a new drug application. The importance of the requirement for adequate stability testing of drug products in their containers is stressed. Sources of various public standards pertaining to testing of drug packaging and component parts are listed.

    Keywords:

    packaging, drugs, plastics industry, drug industry, quality control, containers, standards, polyvinyl chloride, Food and Drug Administration, Federal Food, Drug, and Cosmetic Act, Poison Prevention Packaging Act


    Author Information:

    Kumkumian, CS
    Assistant associate director for new drug evaluation (chemistry), Bureau of Drugs, Food and Drug Administration, Rockville, Md.


    Paper ID: STP27866S

    Committee/Subcommittee: D10.32

    DOI: 10.1520/STP27866S


    CrossRef ASTM International is a member of CrossRef.